Company / Revenue
Oncology Institute, Inc. Revenue History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$393.4M
FY2025
5-year range
$187.5M / $393.4M
FY2021-FY2025
Trend
+21.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue has increased for 4 consecutive years, from $188M in FY2021 to $393M in FY2025.
Based on SEC 10-K filings.
$393M in FY2025 with a 3-year CAGR of +24.7%.
Improved from $252M to $393M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- +24.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Oncology Institute, Inc.'s revenue has grown for 4 consecutive years.
- 3-year CAGR of +24.7%, indicating consistent growth.
- In FY2025, revenue increased 21.3% year-over-year.
- Lowest revenue in the period was in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $393.4M | +21.3% |
| FY2024 | $324.2M | +28.4% |
| FY2023 | $252.5M | +24.4% |
| FY2022 | $203.0M | +8.3% |
| FY2021 | $187.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026